Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail ...

With an FDA-approved treatment like Wegovy, healthcare professionals and patients can have confidence in safety, effectiveness and quality, knowing it has undergone rigorous regulatory review.

NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Such products are not FDA approved, however, meaning the agency does not review them for safety ... that patients would return to branded Wegovy and Ozempic treatments as supply becomes ...